Episode 1 | Hopeful News Network Podcast | Breakthroughs for Parkinson's

Описание к видео Episode 1 | Hopeful News Network Podcast | Breakthroughs for Parkinson's

Join David Gonzalez, Registered Nurse, Clinical Lead, and now Lead Anchor, for Hope Biosciences Research Foundation's (HBRF) inaugural episode of Hopeful News! David is joined in this episode by Registered Nurse Sherry Diers of Hope Biosciences. Hope Bio manufactures the investigational product administered in the FDA-authorized studies presented in this episode.

In this episode:
Hear the latest Parkinson's stem cell research news;
Learn about a remarkable patient who regained her ability to create miniature artwork after long-term repeated treatment with stem cells manufactured by Hope Biosciences, LLC and investigated at HBRF; and
Meet the clinical research scientist behind the five peer-reviewed pieces published by HBRF in 2023.
Hopeful News Network, America's Most Trusted Source for Hopeful News: Communication - Announcements - Research - Clinical Trials

Want to be part of the stories covered at Hopeful News Network? Give the gift of hope, in the form of a tax-deductible donation that goes directly to real people, with real needs, while building a brighter healthcare future for us all. Learn more and give at hopebio.org/donate

As referenced in this episode:

PD01 Press Release: https://hopebio.org/article?id=a1T3h0...

For recently published peer-reviewed work in Parkinson's Disease, see Frontiers in Neurology, "Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report" at https://www.frontiersin.org/journals/...

HBRF is currently enrolling in an FDA-authorized Phase II clinical trial in Parkinson's Disease. Learn more at https://hopebio.org/protocol?name=HBPD04

Dan Crenshaw's Healthcare Innovation Summit and Parkinson's Disease video:    • Congressman Crenshaw’s 2020 Healthcar...  

Long Covid 01 Trial Paper: https://www.ncbi.nlm.nih.gov/pmc/arti...

Комментарии

Информация по комментариям в разработке